Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
about
177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice.Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy."Albumin Hitchhiking" with an Evans Blue Analog for Cancer Theranostics.Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy.A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
P2860
Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel "Add-On" Molecule Based ...... s Drugs to Theranostic Agents.
@en
type
label
Novel "Add-On" Molecule Based ...... s Drugs to Theranostic Agents.
@en
prefLabel
Novel "Add-On" Molecule Based ...... s Drugs to Theranostic Agents.
@en
P2093
P2860
P50
P1476
Novel "Add-On" Molecule Based ...... s Drugs to Theranostic Agents.
@en
P2093
P2860
P304
P356
10.2967/JNUMED.116.182097
P407
P577
2016-11-22T00:00:00Z